One of the joys of investing in stocks is watching dividend payments roll in quarter after quarter. Giant capital gains from growth stocks may be more exciting, but a reliable and growing stream of dividend payments, reinvested in more stocks, unleashes the true power of compounding. Dividends have accounted for nearly half of the total return of the S&P 500 Index over the past 25 years. You....More>>>
Yesterday, our Elite Opportunity Pronewsletter suggested it might be time to get into social media stock Twitter Inc (NYSE: TWTR):
“I’m sure many of you have seen what Twitter (TWTR) is doing today. We did extremely well calling a short-term bottom in the stock earlier in the summer, which ended up providing some nice gains for everyone who jumped in. I’ve included a weekly....More>>>
This is a follow up to my February 9, 2017 Broadridge Financial (NYSE: BR) post. At the time I wrote that post, BR was trading at $68.18. This price was very similar to the price I had paid in August 2016 to acquire additional BR shares; BR is currently trading at $71.07.
Should you be unfamiliar with BR, I suggest you review BR’s March 14, 2017 presentation made....More>>>
A simple view of investment-grade and high-yield corporate bonds is these are instruments sold to investors who, in most cases, are not looking to take on significant. Hence why creditworthiness is an integral part of evaluating corporate bonds.
After all, investors in these bonds not only want income, but their principle back as well. So, it pays to know a company's ability to generate....More>>>
My clear choice for a Top Pick for income investing is a closed-end fund that invests in a variety of both public and private companies doing work in the life sciences sector, asserts Nate Pile, editor of Nate’s Notes.
Tekla Life Sciences Investors (HQL) represents an outstanding way for investors who want to be involved in biotech, but don’t like the high levels of stress....More>>>
On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap data storage systems stock Qualstar Corporation (NASDAQ: QBAK):
Quelstar is essentially a mirror image of Pixelworks. That is, it’s not just the bearish undertow we want to tap into here. It’s the failure of QBAK to follow-through on today’s effort to break above the 100-day moving average line....More>>>
I have written about Global Blood Therapeutics (NASDAQ:GBT) before here. In my prior article, I addressed a number of fairly legitimate concerns people have cited about the stock and its lead drug for sickle cell disease (“SCD”) called GBT-440, and I explained how those risks are less significant than one might believe, or are being successfully mitigated by the company.
Since the beginning of the year, Japanese equities have been one of the worst performing developed markets. Despite the most expansionary monetary policy in the world, Japanese markets plummeted by the greatest percentage in the first seven months of the year and showed no signs of recovery. However, from the second half of the summer, the dynamic of the market started slowly turning back to the....More>>>
It’s mind bending. Scientists believe it is now possible to wind back the biological clock. Aging would not only stop. It would reverse.
Last month, researchers at the Salk Institute in La Jolla, California published a ground breaking study in the medical journal, Cell. Using genetic modification, Juan Carlos Izpisua Belmonte, Alejandro Ocampo and other Salk scientists....More>>>